Hagerman Allison bought ONCY

February 12, 2026 · Form 4 insider transaction

Hagerman Allison bought 10,000 shares of Oncolytics Biotech Inc. at $0.83 per share, a transaction worth $8.3K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.